Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376614241> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4376614241 abstract "Introduction Antiplatelet drugs (AD) reversibly or irreversibly inhibit activation and platelet aggregation and hence inhibit genesis of thrombus. Methods In this article, we review the administration of AD in acute stroke management as well as in the primary and secondary prevention of stroke and transient ischemic attack (TIA). Conclusions For primary stroke prevention of the first ever stroke, aspirin is advised only when a 10-year vascular risk is more than 10%, patient has a likely survival of >10 years and has a low risk for hemorrhage. For patients with acute ischemic stroke (AIS) or TIA administration of aspirin is strongly recommended within 24–48 h of symptom onset. For patients managed with IV thrombolysis, aspirin administration should be deferred for 24 h. For patients with recent minor non cardioembolic AIS and a National Institutes of Health Stroke Scale (NIHSS) score ≤3 or patients with a high-risk TIA with ABCD2 score ≥4, dual Antiplatelet therapy with aspirin and clopidogrel should be started within 12–24 h of stroke or TIA onset and definitely within a week of onset and then should be continued for a period of 21–90 days, followed by switching to a single antiplatelet therapy. The US Food and Drug Administration has given approval for Ticagrelor usage to prevent the risk of for stroke recurrence in patients with AIS with a NIHSS score of ≤5 or high-risk TIA where ticagrelor – Aspirin combination maybe prescribed for 30 days. For patients who are carriers of CYP2C19 a 90-day ticagrelor – Aspirin offers better stroke prevention. ADs in dual combination for short term and single agent in the long term remain the dominant therapy for prevention of non-cardioembolic ischemic stroke." @default.
- W4376614241 created "2023-05-17" @default.
- W4376614241 creator A5011265771 @default.
- W4376614241 creator A5016115618 @default.
- W4376614241 creator A5055379788 @default.
- W4376614241 date "2023-05-16" @default.
- W4376614241 modified "2023-09-26" @default.
- W4376614241 title "Antiplatelets in Acute Management and Prevention of Transient Ischemic Attack and Stroke" @default.
- W4376614241 cites W10734288 @default.
- W4376614241 cites W1991655882 @default.
- W4376614241 cites W2016234644 @default.
- W4376614241 cites W2081615170 @default.
- W4376614241 cites W2097483964 @default.
- W4376614241 cites W2107321252 @default.
- W4376614241 cites W2114635452 @default.
- W4376614241 cites W2142848477 @default.
- W4376614241 cites W2154134447 @default.
- W4376614241 cites W2156641763 @default.
- W4376614241 cites W2168905981 @default.
- W4376614241 cites W2180717194 @default.
- W4376614241 cites W2361921955 @default.
- W4376614241 cites W2397867274 @default.
- W4376614241 cites W2509299184 @default.
- W4376614241 cites W2736138957 @default.
- W4376614241 cites W2804570339 @default.
- W4376614241 cites W3043492355 @default.
- W4376614241 cites W3209828359 @default.
- W4376614241 cites W4245197683 @default.
- W4376614241 cites W4292550095 @default.
- W4376614241 doi "https://doi.org/10.4103/am.am_124_22" @default.
- W4376614241 hasPublicationYear "2023" @default.
- W4376614241 type Work @default.
- W4376614241 citedByCount "0" @default.
- W4376614241 crossrefType "journal-article" @default.
- W4376614241 hasAuthorship W4376614241A5011265771 @default.
- W4376614241 hasAuthorship W4376614241A5016115618 @default.
- W4376614241 hasAuthorship W4376614241A5055379788 @default.
- W4376614241 hasBestOaLocation W43766142411 @default.
- W4376614241 hasConcept C126322002 @default.
- W4376614241 hasConcept C127413603 @default.
- W4376614241 hasConcept C164705383 @default.
- W4376614241 hasConcept C2777628954 @default.
- W4376614241 hasConcept C2777849778 @default.
- W4376614241 hasConcept C2779581417 @default.
- W4376614241 hasConcept C2780645631 @default.
- W4376614241 hasConcept C2780890252 @default.
- W4376614241 hasConcept C2781362458 @default.
- W4376614241 hasConcept C2909112448 @default.
- W4376614241 hasConcept C500558357 @default.
- W4376614241 hasConcept C71924100 @default.
- W4376614241 hasConcept C78519656 @default.
- W4376614241 hasConceptScore W4376614241C126322002 @default.
- W4376614241 hasConceptScore W4376614241C127413603 @default.
- W4376614241 hasConceptScore W4376614241C164705383 @default.
- W4376614241 hasConceptScore W4376614241C2777628954 @default.
- W4376614241 hasConceptScore W4376614241C2777849778 @default.
- W4376614241 hasConceptScore W4376614241C2779581417 @default.
- W4376614241 hasConceptScore W4376614241C2780645631 @default.
- W4376614241 hasConceptScore W4376614241C2780890252 @default.
- W4376614241 hasConceptScore W4376614241C2781362458 @default.
- W4376614241 hasConceptScore W4376614241C2909112448 @default.
- W4376614241 hasConceptScore W4376614241C500558357 @default.
- W4376614241 hasConceptScore W4376614241C71924100 @default.
- W4376614241 hasConceptScore W4376614241C78519656 @default.
- W4376614241 hasLocation W43766142411 @default.
- W4376614241 hasOpenAccess W4376614241 @default.
- W4376614241 hasPrimaryLocation W43766142411 @default.
- W4376614241 hasRelatedWork W1584895772 @default.
- W4376614241 hasRelatedWork W2556414715 @default.
- W4376614241 hasRelatedWork W3041094337 @default.
- W4376614241 hasRelatedWork W3043492355 @default.
- W4376614241 hasRelatedWork W3194397706 @default.
- W4376614241 hasRelatedWork W4200348914 @default.
- W4376614241 hasRelatedWork W4200360015 @default.
- W4376614241 hasRelatedWork W4206427522 @default.
- W4376614241 hasRelatedWork W4281651900 @default.
- W4376614241 hasRelatedWork W4318017329 @default.
- W4376614241 isParatext "false" @default.
- W4376614241 isRetracted "false" @default.
- W4376614241 workType "article" @default.